CryoLife Inc. | |
Stock Exchange | Frankfurt Stock Exchange |
EPS |
- |
Market Cap |
- |
Shares Outstanding |
36.77 M |
Public Float |
30.08 M |
CryoLife Inc. | |
Stock Exchange | New York Stock Exchange |
EPS |
$0.01 |
Market Cap |
$1.14 B |
Shares Outstanding |
37.34 M |
Public Float |
35.21 M |
Address |
1655 Roberts Boulevard NW Kennesaw Georgia 30144 United States |
Employees | - |
Website | http://www.cryolife.com |
Updated | 07/08/2019 |
CryoLife, Inc. is a medical devices company, which engages in the processing and distribution of implantable human tissues for use in cardiac and vascular surgeries. It operates through the Medical Devices and Preservation Services segments. The Medical Devices segment includes BioGlue; BioFoam; On-X products; CardioGenesis cardiac laser therapy; PerClot; PhotoFix, Hemodialysis Reliable Outflow Graft; and ProCol Vascular Bioprosthesis. |